Penile metastasis from prostate cancer: Durable pain control after Ga-68 PSMA PET/CT-guided palliative radiotherapy
Radiation Sciences in Oncology · 2026
DOI: 10.33066/rso.2026.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Sciences in Oncology, 2026. Verfasst von Fatih Özcan und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Penile metastases (PMs) from prostate adenocarcinoma are rare manifestations of advanced disease and are often associated with significant morbidity. Optimal local management strategies remain undefined due to limited published data. Case Presentation: A 65-year-old man with metastatic prostate adenocarcinoma presented with severe penile pain, with a Visual Analog Scale (VAS) score of 8/10. Ga-68 PSMA PET/CT imaging revealed intense focal uptake in the corpus of the penis, consistent with metastatic involvement. Palliative radiotherapy was delivered with a Radixact® helical tomotherapy system, delivering a total dose of 25 Gy in 10 fractions. At three months post-treatment, the VAS score decreased to 2/10. A six-month follow-up Ga-68 PSMA PET/CT demonstrated complete resolution of pathological Ga-68 PSMA expressions in penile metastasis, consistent with a complete response to treatment. The patient remained clinically stable with sustained pain control for nine months.
Conclusion
Palliative radiotherapy delivered at a dose of 25 Gy in 10 fractions achieved durable pain relief and complete resolution of pathological Ga-68 prostate-specific membrane antigen (PSMA) uptake within the penile metastasis, consistent with a complete local response to treatment, in this rare case of penile metastasis from prostate cancer. Ga-68 PSMA PET/CT played a pivotal role by facilitating a non-invasive diagnosis in a highly sensitive anatomical region without the need for an invasive biopsy, enabling accurate delineation of gross tumor volume (GTV) for precise radiotherapy planning, and providing an objective assessment of treatment response during follow-up. Image-guided conformal radiotherapy using helical tomotherapy may represent a feasible and effective organ-preserving option for symptom palliation in selected patients. However, further clinical evidence is required to better define the role of molecular imaging-guided radiotherapy in the management of this rare clinical entity.
Zitieren
APA
Özcan, F., & İlgün, E. (2026). Penile metastasis from prostate cancer: Durable pain control after Ga-68 PSMA PET/CT-guided palliative radiotherapy. Radiation Sciences in Oncology. https://doi.org/10.33066/rso.2026.11
Vancouver
Özcan F, İlgün E. Penile metastasis from prostate cancer: Durable pain control after Ga-68 PSMA PET/CT-guided palliative radiotherapy. Radiation Sciences in Oncology. 2026. doi:10.33066/rso.2026.11
BibTeX
@article{zcan2026,
author = {Özcan, Fatih and İlgün, Esra},
title = {Penile metastasis from prostate cancer: Durable pain control after Ga-68 PSMA PET/CT-guided palliative radiotherapy},
journal = {Radiation Sciences in Oncology},
year = {2026},
doi = {10.33066/rso.2026.11}
}
EUVIMED